Company · founded 1961
Advanced Bioscience Laboratories (United States)
Rockville, United States · ablinc.com
- Citations, last 5 years
- 130
- Works, last 5 years
- 11
- h-index
- 96
- Scientists listed
- 4
- Grants since 2016
- 173
Grants received
2014–2022 · contract · N01
Task X7: Malaria Vaccines Stability Study
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2025 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Δ11 gp120 Env Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task X7: Malaria Vaccines Stability Study
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2023 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Δ11 gp120 Env Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2014–2025 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Δ11 gp120 Env Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
SVEU - MAINTENANCE OF NONHUMAN PRIMATES
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
SVEU - MAINTENANCE OF NONHUMAN PRIMATES
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2022 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of HIV-1 gp120 Protein
Tim Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
Simian Vaccine Evaluation Unit - Core Activities: Administrative and Technical Support
Pal Ranajit · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2022 · contract · N01
SVEU - Core Activities - Administrative and Technical Support
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2021 · contract · N01
NIAID Preclinical Development Support - Production of HIV-gp120 Proteins
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of HIV-1 gp120 Protein
Nancy Lin · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
Evaluation of the Immunogenicity and Efficacy of HIV-1 Clade A BG505 SOSIP.664 Env Glycoprotein Trimer Vaccine Administered with TLR Agonist or Alum Adjuvants
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2022 · contract · N01
SVEU - Core Activities - Administrative and Technical Support
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
Simian Vaccine Evaluation Unit - Operations of a Nonhuman Primate Breeding Colony
Ranajit Pal · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
Simian Vaccine Evaluation Units - Maintenance of Nonhuman Primates
Peter Silvera · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT
Pal Ranajit · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2023 · contract · N01
NIAID Preclinical Development Support - Production of HIV-1 M Group Conserved Element DNAs
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2013–2023 · contract · N01
NIAID Preclinical Development Support - Production of HIV-1 M Group Conserved Element DNAs
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task 13: Product Characterization and Process Development
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Manufacture and Characterization Services for Vaccines and Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
Timothy Fouts · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X12: Development of a Gonorrhea Vaccine
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task 19: GMP Manufacturing for a Malaria Vaccine Phase I Trial
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X20:Master Cell Banks
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Manufacture and Characterization Services for Vaccines and Biologics
(Contact) · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X5: Master Cell Bank for Chlamydia Trachoma Vaccine
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task 13: Product Characterization and Process Development
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X10: Cell Bank Work for Agilvax
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Manufacture and Characterization Services for Vaccines and Biologics
Norman Kneteman · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task 19: GMP Manufacturing for a Malaria Vaccine Phase I Trial
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health
2012–2022 · contract · N01
Task X1: Manufacture and Characterization Services for Vaccines and Biologics
James Richardson · Advanced Bioscience Laboratories (United States) · funded by National Institutes of Health